Trial · NCT03197766
Results by group14
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 14 of 14
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline in Annualized Growth Velocity (AGV) at Week 52 | BMN 111 - 15 μg/kg | 1.71 | 95% Confidence Interval 1.40 to 2.01 | cm/year | |
| Change From Baseline in Annualized Growth Velocity (AGV) at Week 52 | Placebo | 0.13 | 95% Confidence Interval -0.18 to 0.45 | cm/year | |
| Change From Baseline in Height Z-score at Week 52 | BMN 111 - 15 μg/kg | 0.27 | 95% Confidence Interval 0.18 to 0.36 | Z-Score | |
| Change From Baseline in Height Z-score at Week 52 | Placebo | -0.01 | 95% Confidence Interval -0.10 to 0.09 | Z-Score | |
| Change From Baseline in Upper to Lower Segment Body Ratio at Week 52 | BMN 111 - 15 μg/kg | -0.03 | 95% Confidence Interval -0.06 to 0.00 | Ratio | |
| Change From Baseline in Upper to Lower Segment Body Ratio at Week 52 | Placebo | -0.02 | 95% Confidence Interval -0.05 to 0.01 | Ratio | |
| Summary of Subjects Experiencing Adverse Events (AEs) During Treatment | BMN 111 - 15 μg/kg | Subjects with any AE | 59 | participants | |
| Summary of Subjects Experiencing Adverse Events (AEs) During Treatment | Placebo | Subjects with any AE | 60 | participants | |
| Summary of Subjects Experiencing Adverse Events (AEs) During Treatment | BMN 111 - 15 μg/kg | Subjects with any SAE | 3 | participants | |
| Summary of Subjects Experiencing Adverse Events (AEs) During Treatment | Placebo | Subjects with any SAE | 4 | participants | |
| Summary of Subjects Experiencing Adverse Events (AEs) During Treatment | BMN 111 - 15 μg/kg | Subjects with any treatment-related AE | 53 | participants | |
| Summary of Subjects Experiencing Adverse Events (AEs) During Treatment | Placebo | Subjects with any treatment-related AE | 51 | participants | |
| Summary of Subjects Experiencing Adverse Events (AEs) During Treatment | BMN 111 - 15 μg/kg | Subjects who died | 0 | participants | |
| Summary of Subjects Experiencing Adverse Events (AEs) During Treatment | Placebo | Subjects who died | 0 | participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03197766/results